Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
Sign Up to like & getrecommendations! Published in 2020 at "Radiology"
DOI: 10.1148/radiol.2020200978
Abstract: Background Relevance of antiangiogenic treatment with bevacizumab in patients with glioblastoma is controversial because progression-free survival benefit did not translate into an overall survival (OS) benefit in randomized phase III trials. Purpose To perform longitudinal… read more here.
Keywords: bevacizumab; group; bev group; mri ... See more keywords
Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Analysis
Sign Up to like & getrecommendations! Published in 2023 at "Oncology"
DOI: 10.1159/000528081
Abstract: Introduction: We previously reported 2 cases of esophageal varices rupture during atezolizumab and bevacizumab (Atez/Bev) treatment, in which the spleen volume gradually increased. The aim of this retrospective study is to compare the chronological change… read more here.
Keywords: atez bev; group; bev group; spleen volume ... See more keywords